Replidyne

About:

A biopharmaceutical company focused on the discovery and development of new antimicrobial drugs

Top Investors: Morgenthaler Ventures, Johnson & Johnson Development Corporation, HealthCare Ventures, Sequel Venture Partners

Description:

Replidyne is a specialty pharmaceutical company focused on developing and commercializing innovative anti-infective products. The company is building its development pipeline based on both its proprietary DNA replication technology and in-licensing efforts.

Total Funding Amount:

$13M

Headquarters Location:

Louisville, Colorado, United States

Founded Date:

2000-01-01

Founders:

Number of Employees:

1001-5000

Last Funding Date:

2002-04-19

IPO Status:

Public

Industries: